AperçuGraphiqueActualitésTraderScreen

Oncolytics Biotech/  CA6823101077  /

Cboe US
20/12/2024  21:59:30 Chg. -0.05 Volume Bid22:25:01 Demandez à22:25:01 Haut Bas
0.85USD -5.83% 42,091
Chiffrre d'affaires: 35,423.33		 -Bid taille: - -Ask la taille: - 0.88 0.79
GlobeNewswire 12/08 Sernova Corp. Announces Appointment of New Chief Executive Officer
GlobeNewswire 20/06 Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire 20/06 Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire 24/05 Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...
Newsfile Corp 06/03 Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
GlobeNewswire 05/03 Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Trea...
Newsfile Corp 15/02 Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire 14/02 Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focu...
GlobeNewswire 09/01 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire 12/12/2018 Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and t...
GlobeNewswire 03/12/2018 Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasom...
GlobeNewswire 29/11/2018 Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical Officer
GlobeNewswire 26/11/2018 Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytru...
GlobeNewswire 13/11/2018 Oncolytics Biotech® Announces Attendance of Upcoming Conferences
GlobeNewswire 12/11/2018 Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire 09/11/2018 Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Me...
GlobeNewswire 05/11/2018 Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Corporat...
GlobeNewswire 01/11/2018 Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep ...
GlobeNewswire 22/10/2018 Oncolytics Biotech® Announces Positive Clinical Trial Results for Pelareorep in Patients with KRAS M...
GlobeNewswire 11/10/2018 Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract f...
GlobeNewswire 02/10/2018 Oncolytics Biotech® Announces a Publication Demonstrating That Intravenously Delivered Oncolytic Vir...
GlobeNewswire 28/09/2018 Oncolytics Biotech® Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln...
GlobeNewswire 26/09/2018 Oncolytics Biotech® to Present at the Ladenburg Thalmann 2018 Healthcare Conference
GlobeNewswire 19/09/2018 Oncolytics Biotech® Provides Corporate and Clinical Update
GlobeNewswire 17/09/2018 Oncolytics Biotech® Announces Investigator Sponsored Multiple Myeloma Study Combining REOLYSIN® and ...